RPL17 and esophageal squamous cell carcinoma: We clarified PD-1 and PD-L1 expressions, the associations between PD-L1 expression and various immune cells, and the prognostic relevance of these factors employing IHC with tissue microarrays for 196 ESCC cases who had received neither preoperative neoadjuvant therapy nor post-recurrence immunotherapy.